| |
|
|
|
|
|
|
|||
|
BRIEF REPORT
From the Laboratory of Molecular Biology, Clinical
Research Institute of Montreal, Montreal, Quebec, Canada; Departments
of Medicine or Microbiology and Immunology, Université de
Montréal, Montreal, Quebec, Canada; and the Division of
Experimental Medicine, McGill University, Montreal, Quebec, Canada.
To identify the regulatory elements controlling expression of the
human CD4 (hCD4) gene in different cell
types of the immune system, deletion and chimeric (human/murine)
reporter genes were constructed and tested in transgenic (Tg) mice.
Regulatory elements required for the proper hCD4 expression in the
immature double-positive thymic T cells were identified in the enhancer
and in the 3' end of intron 1. Expression of hCD4 in macrophages is
controlled by at least 2 sets of regulatory elements: one present in
front of exon 1 and the second at the 5' end of intron 1. The hCD4
elements required for expression on both myeloid and lymphoid
CD8 The CD4 cell surface receptor is expressed on many
mouse or human cell populations, namely, on very early T-cell
precursors (CD4LowCD44+CD25 Tg mice
Flow cytometry
The Tg mice harboring 6 different DNAs were generated (Figure
1). Northern blot analysis revealed that
expression was highest in the thymus but was also detectable in the
spleen and LNs, and was negative in all other organs tested (liver,
heart, kidney, lung, intestine, muscle, brain; data not shown). This
result is consistent with previous studies indicating that the human
and mouse CD4 promoter/enhancer alone or in combination is sufficient to restrict expression to hematopoietic tissues.7,10-13 As
expected, the level of expression varied among different founders
carrying the same construct, an effect most likely related to the site of integration of the inoculated DNA.
Expression of hCD4 in DP CD4+CD8+ T cells Fluorescent-activated cell sorter (FACS) analysis showed that DP and SP CD4+ thymocytes of CD4E, CD4F, and CD4H Tg mice expressed the hCD4 reporter at high levels, similar to CD4C Tg mice7 (data not shown). Deletion of most of intron 1 (CD4F) or substitution of the human for the mouse promoter (CD4E) did not significantly change expression in the thymic T cells. Therefore, the CD4E and CD4F transgenes contain all the regulatory elements required for promoting CD4 expression in DP T cells. This result is in agreement with data from other groups who used similar human14,15 or mouse10 constructs. In contrast, other Tg mice harboring apparently similar mCD416,17 or hCD418,19 constructs did not express their reporter gene in the CD4+CD8+ DP T cells, while retaining expression in the SP CD4+ T cells. These discrepancies may reflect the presence or not of intronic element(s), just in front of exon 2, required for the expression in DP T cells and identified by Rushton and colleagues20 as the proximal promoter.Silencing of the CD4 promoter in SP CD8+ T cells In all Tg lines, including in most new lines (CD4E, F, H), expression of hCD4 in spleen and LNs was not detected on B cells and was restricted to T cells, almost exclusively on mature CD4+CD8 T cells (80%-90%, Table
1, data not shown). The SP
CD8+ T cells from CD4E and CD4H (about 10%-18%), but not
from CD4F (<3%) Tg mice expressed hCD4 (Figure
2A, Table 1, data not shown), indicating that switching the human with the mouse promoter (CD4E) or
deleting a large portion of the intron 1 (CD4H, CD4F) had no effect on
the expression on CD4+ T cells. These results also showed
that the mouse silencer,10,11 in the context of the human
promoter (CD4F), appears to be more effective in shutting off
expression in CD8+ T cells than the human
silencer14 (CD4H, CD4C). The human silencer may require
additional collaborative sequences, not yet identified, to be fully
operative.
Transgene expression in peritoneal macrophages In CD4A, CD4C, and CD4H Tg mice, hCD4 was expressed on over 85% of peritoneal macrophages (Mac-1+)7 (Figure 2B, Table 1). However, macrophages from the CD4E and CD4F Tg mice showed very low or undetectable levels of expression. These results suggest that expression in macrophages requires the concomitant presence of 2 hCD4 sequences: one located in the 2.6-kbp promoter and a second (about 3.5 kbp) in the 5' intron 1 region (Figure 1).Transgene expression in DCs Because macrophages and DCs can be derived from the same myeloid precursor and because the 2 major mouse subpopulations of DCs ("myeloid" CD11c+CD11b+CD8![]()
and "lymphoid"
CD11c+CD11b CD8 +) are thought
to fulfill different functions in vivo,21 it
was of interest to compare transgene expression in these DC
subpopulations. This comparative analysis was carried out on purified
DCs from peripheral LNs and from thymus. The data are shown for DCs
expressing either a myeloid (CD11c+ CD11b+) or
a lymphoid (CD11c+ CD8 +) phenotype.
In CD4A, CD4C, CD4E, and CD4H Tg mice, expression of hCD4 was detected
in high proportion (80%) on both CD11b+ and
CD8 This work confirms earlier studies in lymphoid T cells on the importance of some regulatory elements within the CD4 gene, the distal promoter,22-24 the proximal promoter,20 the proximal and distal enhancers,13,25,26 and the silencer,10,11,14 and extends them significantly for macrophages and DCs.
We thank Ginette Massé, Nathalie Gauthier, Michel Ste-Marie, Michel Robillard, Stéphane Gagnon, and Karina Lamarre for their excellent technical assistance and Nathalie Tessier for her valuable help in the FACS analysis.
Submitted November 8, 2000; accepted May 31, 2001.
Supported by grants from the Medical Research Council to P.J. and Z.H. and from the National Cancer Institute to P.J.
The publication costs of this article were defrayed in part by page charge payment. Therefore, and solely to indicate this fact, this article is hereby marked "advertisement" in accordance with 18 U.S.C. section 1734.
Reprints: Paul Jolicoeur, Laboratory of Molecular Biology, Clinical Research Institute of Montreal, 110 Pine Ave W, Montreal, QUE, H2W 1R7, Canada; e-mail: jolicop{at}ircm.qc.ca; or Zaher Hanna, Clinical Research Institute of Montreal, 110 Pine Ave W, Montreal, Quebec, H2W 1R7, Canada; e-mail: hannaz{at}ircm.qc.ca.
1. Ellmeier W, Sawada S, Littman DR. The regulation of CD4 and CD8 coreceptor gene expression during T cell development. Ann Rev Immunol. 1999;17:523-554[CrossRef][Medline] [Order article via Infotrieve]. 2. Killeen N, Littman DR. The regulation and function of the CD4 coreceptor during T lymphocyte development. Curr Top Microbiol Immunol. 1996;205:89-106[Medline] [Order article via Infotrieve].
3.
Salomon B, Cohen JL, Masurier C, Klatzmann D.
Three populations of mouse lymph node dendritic cells with different origins and dynamics.
J Immunol.
1998;160:708-717
4.
Vremec D, Pooley J, Hochrein H, Wu L, Shortman K.
CD4 and CD8 expression by dendritic cell subtypes in mouse thymus and spleen.
J Immunol.
2000;164:2978-2986 5. Wood GS, Warner NL, Warnke RA. Anti-Leu-3/T4 antibodies react with cells of monocyte/macrophage and Langerhans lineage. J Immunol. 1983;131:212-216[Abstract].
6.
Kazazi F, Mathijs JM, Foley P, Cunningham AL.
Variations in CD4 expression by human monocytes and macrophages and their relationships to infection with the human immunodeficiency virus.
J Gen Virol.
1989;70:2661-2672
7.
Hanna Z, Simard C, Jolicoeur P.
Specific expression of the human CD4 gene in mature CD4+CD8
8.
Berney C, Herren S, Power CA, Gordon S, Martinez-Pomares L, Kosco-Vilbois MH.
A member of the dendritic cell family that enters B cell follicles and stimulates primary antibody responses identified by a mannose receptor fusion protein.
J Exp Med.
1999;190:851-860
9.
Vremec D, Zorbas M, Scollay R, et al.
The surface phenotype of dendritic cells purified from mouse thymus and spleen: investigation of the CD8 expression by a subpopulation of dendritic cells.
J Exp Med.
1992;176:47-58 10. Sawada S, Scarborough JD, Killeen N, Littman DR. A lineage-specific transcriptional silencer regulates CD4 gene expression during T lymphocyte development. Cell. 1994;77:917-929[CrossRef][Medline] [Order article via Infotrieve]. 11. Siu G, Wurster AL, Duncan D, Soliman TM, Hedrick SM. A transcriptional silencer controls the developmental expression of the CD4 gene. EMBO J. 1994;13:3570-3579[Medline] [Order article via Infotrieve].
12.
Gillespie FP, Doros L, Vitale J, Blackwell C, Gosselin J, Snyder BW.
Tissue-specific expression of human CD4 in transgenic mice.
Mol Cell Biol.
1993;13:2952-2958
13.
Blum MD, Wong GT, Higgins KM, Sunshine MJ, Lacy E.
Reconstitution of subclass-specific expression of CD4 in thymocytes and peripheral T cells of transgenic mice: identification of a human CD4 enhancer.
J Exp Med.
1993;177:1343-1358 14. Donda A, Schulz M, Burki K, De Libero G, Uematsu Y. Identification and characterization of a human CD4 silencer. Eur J Immunol. 1996;26:493-500[Medline] [Order article via Infotrieve].
15.
Uematsu Y, Donda A, De Libero G.
Thymocytes control the CD4 gene differently from mature T lymphocytes.
Int Immunol.
1997;9:179-187 16. Duncan DD, Adlam M, Siu G. Asymmetric redundancy in CD4 silencer function. Immunity. 1996;4:301-311[CrossRef][Medline] [Order article via Infotrieve].
17.
Adlam M, Duncan DD, Ng DK, Siu G.
Positive selection induces CD4 promoter and enhancer function.
Int Immunol.
1997;9:877-887 18. Salmon P, Boyer O, Lores P, Jami J, Klatzmann D. Characterization of an intronless CD4 minigene expressed in mature CD4 and CD8 T cells, but not expressed in immature thymocytes. J Immunol. 1996;156:1873-1879[Abstract]. 19. Boyer O, Zhao JC, Cohen JL, et al. Position-dependent variegation of a CD4 minigene with targeted expression to mature CD4+ T cells. J Immunol. 1997;159:3383-3390[Abstract]. 20. Rushton JJ, Zorich GP, Stolc V, Neudorf SM. Characterization of a promoter within the first intron of the human CD4 gene. Eur J Biochem. 1997;245:768-773[Medline] [Order article via Infotrieve]. 21. Shortman K. Burnet Oration: Dendritic cells: multiple subtypes, multiple origins, multiple functions. Immunol Cell Biol. 2000;78:161-165[CrossRef][Medline] [Order article via Infotrieve].
22.
Siu G, Wurster AL, Lipsick JS, Hedrick SM.
Expression of the CD4 gene requires a Myb transcription factor.
Mol Cell Biol.
1992;12:1592-1604 23. Duncan D, Stupakoff A, Hedrick SM, Marcu KB, Siu G. A Myc-associated zinc finger protein binding site is one of four important functional regions in the CD4 promoter. Mol Cell Biol. 1995;15:3179-3186[Abstract].
24.
Salmon P, Giovane A, Wasylyk B, Klatzmann D.
Characterization of the human CD4 gene promoter: transcription from the CD4 gene core promoter is tissue-specific and is activated by Ets proteins.
Proc Natl Acad Sci U S A.
1993;90:7739-7743
25.
Wurster AL, Siu G, Leiden JM, Hedrick SM.
Elf-1 binds to a critical element in a second CD4 enhancer.
Mol Cell Biol.
1994;14:6452-6463
26.
Sawada S, Littman DR.
Identification and characterization of a T-cell-specific enhancer adjacent to the murine CD4 gene.
Mol Cell Biol.
1991;11:5506-5515
© 2001 by The American Society of Hematology.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
![]() |
E. Priceputu, Z. Hanna, C. Hu, M.-C. Simard, P. Vincent, S. Wildum, M. Schindler, F. Kirchhoff, and P. Jolicoeur Primary Human Immunodeficiency Virus Type 1 Nef Alleles Show Major Differences in Pathogenicity in Transgenic Mice J. Virol., May 1, 2007; 81(9): 4677 - 4693. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Li, E. Calvo, M. Cool, P. Chrobak, D. G. Kay, and P. Jolicoeur Overexpression of Notch1 Ectodomain in Myeloid Cells Induces Vascular Malformations through a Paracrine Pathway Am. J. Pathol., January 1, 2007; 170(1): 399 - 415. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Priceputu, I. Bouallaga, Y. Zhang, X. Li, P. Chrobak, Z. S. Hanna, J. Poudrier, D. G. Kay, and P. Jolicoeur Structurally Distinct Ligand-Binding or Ligand-Independent Notch1 Mutants Are Leukemogenic but Affect Thymocyte Development, Apoptosis, and Metastasis Differently J. Immunol., August 15, 2006; 177(4): 2153 - 2166. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Priceputu, I. Rodrigue, P. Chrobak, J. Poudrier, T. W. Mak, Z. Hanna, C. Hu, D. G. Kay, and P. Jolicoeur The Nef-Mediated AIDS-Like Disease of CD4C/Human Immunodeficiency Virus Transgenic Mice Is Associated with Increased Fas/FasL Expression on T Cells and T-Cell Death but Is Not Prevented in Fas-, FasL-, Tumor Necrosis Factor Receptor 1-, or Interleukin-1{beta}-Converting Enzyme-Deficient or Bcl2-Expressing Transgenic Mice J. Virol., May 15, 2005; 79(10): 6377 - 6391. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. de Repentigny, D. Lewandowski, and P. Jolicoeur Immunopathogenesis of Oropharyngeal Candidiasis in Human Immunodeficiency Virus Infection Clin. Microbiol. Rev., October 1, 2004; 17(4): 729 - 759. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Poudrier, X. Weng, D. G. Kay, Z. Hanna, and P. Jolicoeur The AIDS-Like Disease of CD4C/Human Immunodeficiency Virus Transgenic Mice Is Associated with Accumulation of Immature CD11bHi Dendritic Cells J. Virol., November 1, 2003; 77(21): 11733 - 11744. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. G. Kay, P. Yue, Z. Hanna, S. Jothy, E. Tremblay, and P. Jolicoeur Cardiac Disease in Transgenic Mice Expressing Human Immunodeficiency Virus-1 Nef in Cells of the Immune System Am. J. Pathol., July 1, 2002; 161(1): 321 - 335. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-C. Simard, P. Chrobak, D. G. Kay, Z. Hanna, S. Jothy, and P. Jolicoeur Expression of Simian Immunodeficiency Virus nef in Immune Cells of Transgenic Mice Leads to a Severe AIDS-Like Disease J. Virol., March 19, 2002; 76(8): 3981 - 3995. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2001 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||